@colleenyoung they are waiting for an amendment to the clinical study to allow patients with autoimmune disease (like me) into the study. The other location has received the amendment, and they are hoping this location will receive it within 2 weeks. If not I will get another mri of the palate bone in my mouth and if the tumor has grown I will start rituximab mono therapy.

@colleenyoung I was accepted into the trial and will be receiving Mosunetuzumab as a first line treatment for previously untreated low tumor burden follicular non-hogkins lymphoma.